000			02195nam a22003495i 4500
001			81702
003			ES-MaUEC
005			20230207040342.0
007			cr nn 008mamaa
008			141029s2015 ne | s |||| 0|eng d
020			_a9789401795234
040			_aES-MaUEC
050		4	_aRB53 _b.U756 2015 EB
245	0	0	_aUrine Proteomics in Kidney Disease Biomarker Discovery _cedited by Youhe Gao
260			_aDordrecht, Netherlands _bSpringer _c2015
300			_a1 recurso en línea (XIII, 203 p.) _b25 il., 10 il. col.
336			_aTexto (visual) _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
490	1		_aAdvances in Experimental Medicine and Biology _x0065-2598 _v845
520			_aThis book systematically summarizes the ideas and technologies used in urine proteome analysis. It argues that change is the core of biomarker definition since the body uses its homeostatic mechanisms to correct changes in the blood. This means that urine is probably a better source of biomarkers than blood. A roadmap to the urinary biomarker era is proposed, and researchers are reminded of the potential opportunities and risks in their study design. Kidney diseases are emphasized as they produce the most significant changes in urine. This book tries to show researchers and graduate students, who are in or entering the field, "all things considered" rather than "the current affair".Â{uE035}
942			_2lcc _cLE
988			_aEBOOK, EBSPRINGER
650		7	_aOrina _xAnálisis _9192364 _0comprobar BNE19922572624 _2embne
700	1		_aGao, Youhe _eeditor literario _994278 _0Local
830		0	_aAdvances in Experimental Medicine and Biology _x0065-2598 _v845 _9133153
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-94-017-9523-4 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901			_ai9789401795234
907			_a.b12902925 _b10-10-17 _c18-01-16
998			_am _a_alco _a_vill _b22-03-17 _cm _dz _eo _feng _gne _h0
945			_aRB53 .U756 2015 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11572541 _z06-04-17
999			_c81702 _d81702 _x1